Skip to main content
. Author manuscript; available in PMC: 2021 Dec 26.
Published in final edited form as: Nat Protoc. 2021 Apr 28;16(5):2471–2498. doi: 10.1038/s41596-021-00505-5

Fig. 2 ∣. Step-by-step protocol.

Fig. 2 ∣

A summary of the procedures described in the two-phase protocol, highlighting the distinction between in vitro and in vivo samples. Phase 1 focuses on analyzing the expression of general markers of senescence. Phase 2 measures markers that are specific for senescence subtypes. MS, mass spectrometry. Procedure step numbers are shown in red.